Genome-guided cancer treatment decision support
MH Guide identifies safe and effective therapies for cancer patients by analyzing the cancer’s molecular profile. It matches detected mutations to the world’s knowledge in the field of oncology and helps medical experts to create a patient-specific clinical report.
Finding safe and effective therapies for cancer patients
MH Guide is a treatment decision support software for oncologists, molecular pathologists, and clinical laboratories. It translates complex genetic data from cancer samples into actionable clinical insights, helping physicians to find targeted therapies, immunotherapies, and clinical trials for their patients, personalized medicine becomes a reality.
Approved for clinical use
Registered as an IVD medical device in the EU, MH Guide is designed for clinical use.
Molecular Health has been CAP- and CLIA-certified since 2016, the first international bioinformatics dry laboratory to achieve this milestone.
Our compliance with rigorous international standards means you can rely on the results with confidence.
Reimbursement agreements are in place with major payers for pediatric and ovarian cancers, with negotiations in process for other cancer types.
World-class knowledge database
Medical professionals benefit in their daily practice from actionable clinical insights based on Molecular Health’s proprietary knowledge platform, Dataome. Dataome integrates expert-curated, up-to-date, and medically approved clinico-molecular variant interpretations (CVIs) based on scientific peer-reviewed literature, genome studies, and reference databases.
Molecular Health is an independent provider, and MH Guide is assay-agnostic, capable of analyzing data from a variety of established genetic and molecular tests for cancer.
Focus on the clinically most relevant variants, automatically filtered and matched to CVIs providing personalized, country-specific disease, drug, and clinical trial information for each patient.
Quick report generation
MH Guide automatically generates individual patient reports that can be refined and signed off by medical experts. Reports use a well-designed, customizable template and can be downloaded in various formats (PDF, json, XML).
MH Guide’s streamlined workflow allows faster turnover for high throughput of analyses.
Convenient ordering process
Easy to order using MH’s user-friendly ordering application, MH Order portal.
Secure data transmission
Sensitive patient data is transmitted and stored using advanced encryption standards (SSL/TLS, AES-256).
IT infrastructure suits a range of customers, from smaller units to high throughput organizations.
Flexible input formats
Choose from VCF, FASTQ, BAM.
Guaranteed patient data security
MH Guide meets the requirements of HIPAA in the US and the GDPR in Europe as well as the GenDG in Germany.
Suits different use models and budgets
Products available for clinical and research use
Highly customizable output
Report design, content, and format can be tailored to suit your needs.
Powerful applications for hereditary disease analysis
Molecular Health Guide Mendel (MH Mendel) supports human geneticists to identify clinically significant genetic variants and create a diagnostic report for individual patients. MH Mendel is part of the Molecular Health Guide (MH Guide) solution which is an IVD registered in the EU.
Molecular Health Guide BRCA (MH BRCA) supports medical professionals in identifying and reporting clinically significant germline variants associated with hereditary breast and ovarian cancer (HBOC) syndrome from NGS-based assessment of BRCA1 and BRCA2 and other HBOC related genes. MH BRCA is part of the Molecular Health Guide (MH Guide) solution which is an IVD registered in the EU.
Let’s talk about how our technology can work for you
To find out more, you can call our customer care team or help desk or send us an e-mail. We would be delighted to provide you with more information or answer your questions.